Prevention Habits of Medical Doctors
Condition(s) studied
Investigational drug(s) / intervention(s)
PREVMED questionnaire: Anonymous self-administered online questionnaire assessing physicians' preventive practices toward their patients, as well as sociodemographic, occupational, and lifestyle factors that may influence these practices.
Study summary
Preventive practices among physicians remain insufficiently studied, particularly in situations for which recommendations are limited or unavailable.
The PREVMED study aims to describe physicians' preventive practices and to investigate the sociodemographic, occupational, and lifestyle factors that may influence these practices.
Eligibility
Primary outcome measure(s)
- Assessment of patients' preventive health behaviors — Baseline
Frequency of assessment of patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent assessment. - Oral preventive advice provided to patients — Baseline
Frequency of oral advice provided to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent provision of oral advice. - Written preventive advice or treatment prescribed to patients — Baseline
Frequency of written advice or treatment prescribed to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent prescription of written advice or treatment. - Referral to dedicated preventive consultations — Baseline
Frequency of referral of patients to dedicated consultations for physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent referral. - Verification of recommended screening and medical examinations — Baseline
Frequency with which physicians ensure that patients undergo mammography for organized breast cancer screening, cervical screening, fecal occult blood testing for organized colorectal cancer screening, and regular blood tests. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent verification. - Lung cancer screening practice — Baseline
Frequency of proposing lung cancer screening to asymptomatic patients at risk, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of lung cancer screening. - Breast palpation practice — Baseline
Frequency of proposing breast palpation to patients, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of breast palpation. - Cervical screening practice — Baseline
Frequency of proposing cervical screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of cervical screening. - Prostate cancer screening practice — Baseline
Frequency of proposing prostate cancer screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of prostate cancer screening. - Recommendation of skin self-examination — Baseline
Frequency of advising patients to perform skin self-examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent recommendation of skin self-examination. - Visual skin examination — Baseline
Frequency of performing visual skin examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent visual skin examination. - Frequency of screening blood tests — Baseline
Frequency of prescription of screening blood tests, categorized as occasionally without a defined frequency, once a year, once every 2 years, every 3 to 5 years, more than 5 years apart, or more than 10 years apart.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Clermont-Ferrand University Hospital | Clermont-Ferrand | France | Recruiting |
More University Hospital, Clermont-Ferrand trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07829601 on ClinicalTrials.gov ↗ ← All trials in France